Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma.

Yarchoan M, Agarwal P, Villanueva A, Rao S, Dawson LA, Llovet JM, Finn RS, Groopman JD, El-Serag HB, Monga SP, Wang XW, Karin M, Schwartz RE, Tanabe KK, Roberts LR, Gunaratne PH, Tsung A, Brown KA, Lawrence TS, Salem R, Singal AG, Kim AK, Rabiee A, Resar L, Hoshida Y, He AR, Ghoshal K, Ryan PB, Jaffee EM, Guha C, Mishra L, Coleman CN, Ahmed MM.

Cancer Res. 2019 Sep 1;79(17):4326-4330. doi: 10.1158/0008-5472.CAN-19-0803.

PMID:
31481419
2.

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges.

Liu X, Qin S.

Oncologist. 2019 Feb;24(Suppl 1):S3-S10. doi: 10.1634/theoncologist.2019-IO-S1-s01.

3.

Liver transplantation for hepatocellular carcinoma on cirrhosis: strategies to avoid tumor recurrence.

Vivarelli M, Risaliti A.

World J Gastroenterol. 2011 Nov 21;17(43):4741-6. doi: 10.3748/wjg.v17.i43.4741.

4.

Emerging therapies in advanced hepatocellular carcinoma.

Medavaram S, Zhang Y.

Exp Hematol Oncol. 2018 Aug 3;7:17. doi: 10.1186/s40164-018-0109-6. eCollection 2018. Review.

5.

Liver transplantation for hepatocellular carcinoma: current role and future opportunities.

Koller FL, Geevarghese SK, Gorden DL.

Curr Pharm Des. 2007;13(32):3265-73. Review.

PMID:
18045177
6.

Hepatocellular Carcinoma: Current Concepts in Diagnosis, Staging and Treatment.

Schütte K, Schulz C, Malfertheiner P.

Gastrointest Tumors. 2014 Jun;1(2):84-92. doi: 10.1159/000362583. Epub 2014 May 9. Review.

7.

A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma.

Dhir M, Melin AA, Douaiher J, Lin C, Zhen WK, Hussain SM, Geschwind JF, Doyle MB, Abou-Alfa GK, Are C.

Ann Surg. 2016 Jun;263(6):1112-25. doi: 10.1097/SLA.0000000000001556. Review.

PMID:
26813914
8.

Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.

Wang EA, Stein JP, Bellavia RJ, Broadwell SR.

Int J Clin Pract. 2017 Nov;71(11). doi: 10.1111/ijcp.12972. Epub 2017 Jul 30. Review.

PMID:
28758319
9.

Management strategies for hepatocellular carcinoma: old certainties and new realities.

Mazzoccoli G, Tarquini R, Valoriani A, Oben J, Vinciguerra M, Marra F.

Clin Exp Med. 2016 Aug;16(3):243-56. doi: 10.1007/s10238-015-0368-z. Epub 2015 Jun 16. Review.

PMID:
26077653
10.

Liver transplantation for hepatocellular carcinoma: an update.

Zarrinpar A, Kaldas F, Busuttil RW.

Hepatobiliary Pancreat Dis Int. 2011 Jun;10(3):234-42. Review.

PMID:
21669564
11.

Treatment algorithms for managing hepatocellular carcinoma.

Saraswat VA, Pandey G, Shetty S.

J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S80-9. doi: 10.1016/j.jceh.2014.05.004. Epub 2014 Jun 6. Review.

12.

Systemic therapy for hepatocellular carcinoma (HCC): from bench to bedside.

Abdel-Rahman O.

J Egypt Natl Canc Inst. 2013 Dec;25(4):165-71. doi: 10.1016/j.jnci.2013.08.002. Epub 2013 Sep 21. Review.

13.

Hepatocellular carcinoma: systemic therapies and future perspectives.

Mikhail S, Cosgrove D, Zeidan A.

Expert Rev Anticancer Ther. 2014 Oct;14(10):1205-18. doi: 10.1586/14737140.2014.949246. Epub 2014 Sep 9. Review.

PMID:
25199765
14.

Role of Systemic Therapy and Future Directions for Hepatocellular Carcinoma.

Eatrides J, Wang E, Kothari N, Kim R.

Cancer Control. 2017 Jul-Sep;24(3):1073274817729243. doi: 10.1177/1073274817729243. Review.

15.

Hepatitis C and hepatocellular carcinoma.

Yao F, Terrault N.

Curr Treat Options Oncol. 2001 Dec;2(6):473-83. Review.

PMID:
12057093
16.

Management of hepatocellular in the United States.

Mokdad AA, Hester CA, Singal AG, Yopp AC.

Chin Clin Oncol. 2017 Apr;6(2):21. doi: 10.21037/cco.2017.04.04. Review.

17.

Systemic Therapy for Advanced Hepatocellular Carcinoma in an Evolving Landscape.

Mody K, Abou-Alfa GK.

Curr Treat Options Oncol. 2019 Jan 11;20(2):3. doi: 10.1007/s11864-019-0601-1. Review.

PMID:
30635732
18.
19.

Approach to radiation therapy in hepatocellular carcinoma.

Ma S, Jiao B, Liu X, Yi H, Kong D, Gao L, Zhao G, Yang Y, Liu X.

Cancer Treat Rev. 2010 Apr;36(2):157-63. doi: 10.1016/j.ctrv.2009.11.008. Epub 2009 Dec 23. Review.

PMID:
20031332
20.

Goals and targets for personalized therapy for HCC.

Couri T, Pillai A.

Hepatol Int. 2019 Mar;13(2):125-137. doi: 10.1007/s12072-018-9919-1. Epub 2019 Jan 1. Review.

PMID:
30600478

Supplemental Content

Support Center